In a recent study carried out with oral squamous cell carcinoma models, Kowshik et al. reported that ASTX inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signaling axis [43]. This evidence concerns the gene PIK3CB and oral cavity squamous cell carcinoma.